Precious Metals

[EHRjunkie]

$HALB 0.007

Here we go!!!!!

https://www.accesswire.com/604004/Halberd-Selects-Arizona-State-University-ASU-to-Develop-Its-Patented-COVID-19-TreatmentsHalberd Selects Arizona State University (ASU) to Develop Its Patented COVID-19 Treatment(s)

Monday, August 31, 2020 8:00 AM

JACKSON CENTER, PA / ACCESSWIRE / August 31, 2020 / Halberd Corporation (OTC PINK:HALB) today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd's Covid-19 treatments. The work will focus on developing antibodies in support of Halberd's two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of the virus' antigens from a patient's blood. It will also focus on neutralizing the effects of antigens and development of a potential therapeutic medication.

William A. Hartman, Chairman, President and CEO of Halberd Corporation stated, "ASU has demonstrated its expertise in biomedical research, including in the coronavirus arena through its recent development of the first Covid-19 saliva-based diagnostic test."